Gyre Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | — | $-4.2M | $-4.1M |
| Jun 2017 | $111.0K | $-5.9M | $-5.9M |
| Sep 2017 | $318.0K | $-5.9M | $-5.8M |
| Mar 2018 | $6.0K | $-6.7M | $-5.0M |
| Jun 2018 | — | $-7.1M | $-6.5M |
| Sep 2018 | — | $-8.3M | $-7.7M |
| Mar 2019 | — | $-15.7M | $-15.1M |
| Jun 2019 | — | $-14.4M | $-13.8M |
| Sep 2019 | — | $-13.2M | $-12.7M |
| Mar 2020 | $16.4M | $-5.1M | $-4.1M |
| Jun 2020 | $1.7M | $-17.4M | $-17.2M |
| Sep 2020 | $893.0K | $-16.1M | $-16.0M |
| Mar 2021 | $1.5M | $-22.4M | $-22.4M |
| Jun 2021 | $1.1M | $-19.9M | $-19.9M |
| Sep 2021 | $2.3M | $-25.2M | $-25.2M |
| Mar 2022 | $794.0K | $-14.7M | $-14.5M |
| Jun 2022 | — | $51.5M | $51.6M |
| Sep 2022 | — | $-5.2M | $-4.9M |
| Mar 2023 | $24.9M | $6.7M | $4.2M |
| Jun 2023 | $29.3M | $5.0M | $3.8M |
| Sep 2023 | $32.0M | $12.8M | $7.5M |
| Mar 2024 | $27.2M | $8.1M | $9.9M |
| Jun 2024 | $25.2M | $3.2M | $4.5M |
| Sep 2024 | $25.5M | $4.2M | $2.9M |
| Mar 2025 | $22.1M | $2.3M | $4.9M |
| Jun 2025 | $29.7M | $-2.2M | $-2.2M |
| Sep 2025 | $30.6M | $6.9M | $5.9M |
| Mar 2026 | $22.5M | $-9.4M | $-18.6M |
| Jun 2026 | $29.1M | $-14.4M | $-14.3M |